17th International Conference on Malignant Lymphoma, Palazzo dei Congressi, Lugano, Switzerland, 13 - 17 June, 2023.

Cho, S; Kim, T M; Taszner, M; Chen, T Y; Chaudhry, A; Ufkin, M; Uppala, A; Sabir, A; Mohamed, H; Ambati, S; Bachy, E

Cho, S; Kim, T M; Taszner, M; Chen, T Y; Chaudhry, A; Ufkin, M; Uppala, A; Sabir, A; Mohamed, H; Ambati, S; Bachy, E.

Afiliação

Cho S; Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul, Korea.
Kim TM; Seoul National University Hospital, Seoul, Korea.
Taszner M; Department of Haematology and Transplantology, Faculty of Medicine, Medical University of Gdansk, Gdansk, Poland.
Chen TY; Department of Internal Medicine, National Cheng Kung University Hospital, Tainan, Taiwan.
Chaudhry A; Regeneron Pharmaceuticals, Inc., Tarrytown, New York, USA.
Ufkin M; Regeneron Pharmaceuticals, Inc., Tarrytown, New York, USA.
Uppala A; Regeneron Pharmaceuticals, Inc., Tarrytown, New York, USA.
Sabir A; Regeneron Pharmaceuticals, Inc., Tarrytown, New York, USA.
Mohamed H; Regeneron Pharmaceuticals, Inc., Tarrytown, New York, USA.
Ambati S; Regeneron Pharmaceuticals, Inc., Tarrytown, New York, USA.
Bachy E; Department of Hematology, Lyon Sud Hospital, Lymphoma Immuno-Biology (LIB) Team, Inserm U1111, CIRI, Lyon, France.

Hematol Oncol ; 41 Suppl 2: 846-847, 2023 Jun.

Article em En | MEDLINE | ID: mdl-39112277

Assuntos

Linfoma; Humanos; Linfoma/terapia; Suíça; Congressos como Assunto

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfoma Limite: Humans País/Região como assunto: Europa Idioma: En Revista: Hematol Oncol Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google